$ 0 0 Pharnext Announces Encouraging Data from Open ‐ Label Phase 3 Extension Study of PXT3003 The post Pharnext Announces Encouraging Data from Open ‐ Label Phase 3 Extension Study of PXT3003 appeared first on Charcot-Marie-Tooth UK.